december, 2020

07dec(dec 7)1:00 am31jan(jan 31)1:00 amICTR Announces New Biodesign and Innovation Program – Seeking Postdoctoral Applicants


Event Details

The ICTR would like to invite Postdoctoral Fellows (MD’s including residents and fellows as well as Ph.D. post-docs) to apply for an innovative and exciting, NIH funded TL1 Training Program in Biodesign and Innovation sponsored by The Johns Hopkins Institute for Clinical and Translational Research. The one-year program provides salary and tuition support, with the following options:
1. Earning a Master’s Degree in Biodesign and Innovation in the Whiting School of Engineering (CBID). CBID will be accepting MSE applications for the 2021-2022 academic year through December 31, 2020.
2. Mentor-led project in any Department
Biodesign develops trainee skills and awareness in a wide range of topics, such as design principles, technical functionality, evaluation, regulation, reimbursement, and organizational leadership. It creates leaders who understand what it takes to drive innovative solutions to clinical impact in the real world, and increases the value of the investment the DoM and SoM are making in translation and commercialization.
Completed applications are due by Friday, January 8th, 2021. Preferred candidates are those who can commit 1-year fulltime to the program. With the option to begin April – July 2021. (part-time option is also available):
a) Interested in a career focused in biodesign, innovation and translation to the healthcare impact or mentor-led project in any department
b) MD or PhD Health-professional
c) US citizenship, permanent resident, or non-citizen national status (persons born in outlying possessions of the U.S.)
Also, attached is our Request for Applications (RFA), detailing the program and application requirements. Please visit our website for more information and to locate the link to our online application at:
Any questions, please contact Stacey Marks, the Program Manager at


December 7 (Monday) 1:00 am - January 31 (Sunday) 1:00 am

Leave a comment